Differences in Regional Anesthesia Utilization by Hospital Region in the United States.
aclr
neuraxial anesthesia
peripheral nerve block
regional anesthesia
spinal anesthesia
tka
trends analysis
tsa
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
accepted:
04
08
2023
medline:
13
11
2023
pubmed:
13
11
2023
entrez:
13
11
2023
Statut:
epublish
Résumé
Regional anesthesia has been associated with improved postoperative outcomes. Disparities in regional anesthesia utilization exist; however, no studies have examined utilization rates as a function of hospital region. A national hospital database (Hospital Corporation of America {HCA}) was queried for patients aged 18 years or older that received selected surgical procedure codes between January 2016 and June 2021. Surgical procedures included were total knee arthroplasty (TKA), total shoulder arthroplasty (TSA), anterior cruciate ligament reconstruction (ACLR), carpal tunnel release, total abdominal hysterectomy (TAH), open reduction and internal fixation (ORIF) of the ankle, and arteriovenous (AV) fistula creation. Regional anesthesia was defined as any form of neuraxial and/or peripheral nerve blocks. Basic summary statistics were utilized to calculate the rates of regional anesthesia (RA), and chi-squared analyses were calculated to determine significant differences in the rate of RA utilization. There were 52,068 patients included in this study, of which 2,114 (4.1%) received RA. The greatest RA rates were for TSA (5.8%), TKA (4.5), and anterior cruciate ligament reconstruction (ACLR) (3.6%), whereas the lowest RA rate was for TAH (1.1%). For the TKA cohort, the Midwest had a significantly greater utilization rate than the South or West (10.9% vs. 4.8% or 3.1%, p<0.001). The Midwest also had the highest utilization rate in the ACLR cohort (8.1%, p<0.001), TAH cohort (16.7%, p<0.001), and AV fistula cohort (6.4%, p<0.001). For the carpal tunnel cohort, the West had the highest utilization rate (11.8% vs. 8.1%, 1.1%, 0%, p<0.001). The West region also had the highest utilization rate for the ankle ORIF (7.8%, p<0.001). No significant differences were found by region for TSA (p=0.31). Significant variations in RA utilization rates were found by region, with the West having the highest utilization for ankle ORIF and carpal tunnel, and the Midwest having the highest rate for TKA, ACLR, TAH, and AV fistula.
Sections du résumé
BACKGROUND
BACKGROUND
Regional anesthesia has been associated with improved postoperative outcomes. Disparities in regional anesthesia utilization exist; however, no studies have examined utilization rates as a function of hospital region.
METHODS
METHODS
A national hospital database (Hospital Corporation of America {HCA}) was queried for patients aged 18 years or older that received selected surgical procedure codes between January 2016 and June 2021. Surgical procedures included were total knee arthroplasty (TKA), total shoulder arthroplasty (TSA), anterior cruciate ligament reconstruction (ACLR), carpal tunnel release, total abdominal hysterectomy (TAH), open reduction and internal fixation (ORIF) of the ankle, and arteriovenous (AV) fistula creation. Regional anesthesia was defined as any form of neuraxial and/or peripheral nerve blocks. Basic summary statistics were utilized to calculate the rates of regional anesthesia (RA), and chi-squared analyses were calculated to determine significant differences in the rate of RA utilization.
RESULTS
RESULTS
There were 52,068 patients included in this study, of which 2,114 (4.1%) received RA. The greatest RA rates were for TSA (5.8%), TKA (4.5), and anterior cruciate ligament reconstruction (ACLR) (3.6%), whereas the lowest RA rate was for TAH (1.1%). For the TKA cohort, the Midwest had a significantly greater utilization rate than the South or West (10.9% vs. 4.8% or 3.1%, p<0.001). The Midwest also had the highest utilization rate in the ACLR cohort (8.1%, p<0.001), TAH cohort (16.7%, p<0.001), and AV fistula cohort (6.4%, p<0.001). For the carpal tunnel cohort, the West had the highest utilization rate (11.8% vs. 8.1%, 1.1%, 0%, p<0.001). The West region also had the highest utilization rate for the ankle ORIF (7.8%, p<0.001). No significant differences were found by region for TSA (p=0.31).
CONCLUSION
CONCLUSIONS
Significant variations in RA utilization rates were found by region, with the West having the highest utilization for ankle ORIF and carpal tunnel, and the Midwest having the highest rate for TKA, ACLR, TAH, and AV fistula.
Identifiants
pubmed: 37954698
doi: 10.7759/cureus.46795
pmc: PMC10634528
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e46795Informations de copyright
Copyright © 2023, Beletsky et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
BJA Educ. 2018 Feb;18(2):52-56
pubmed: 33456810
Anesthesiology. 2013 May;118(5):1046-58
pubmed: 23612126
JAMA Netw Open. 2021 Nov 1;4(11):e2133394
pubmed: 34779845
Medicine (Baltimore). 2021 Dec 23;100(51):e28438
pubmed: 34941197
Indian J Anaesth. 2021 Mar;65(3):191-196
pubmed: 33776108
Reg Anesth Pain Med. 2020 Sep;45(9):716-719
pubmed: 32699102
Anaesthesia. 2021 Jan;76 Suppl 1:53-64
pubmed: 33426656
J Clin Anesth. 2007 Feb;19(1):67-74
pubmed: 17321932
Respir Care. 2021 Dec;66(12):1789-1796
pubmed: 34548408
Anesth Analg. 2022 May 1;134(5):1072-1081
pubmed: 35313323
HSS J. 2020 Dec;16(Suppl 2):425-435
pubmed: 33380977
Local Reg Anesth. 2020 Oct 22;13:147-158
pubmed: 33122941
CJEM. 2022 Jan;24(1):50-54
pubmed: 34669173
Anesth Analg. 2020 Dec;131(6):1830-1839
pubmed: 32739962
Korean J Pain. 2021 Jan 01;34(1):82-93
pubmed: 33380571
Paediatr Anaesth. 2021 Nov;31(11):1161-1169
pubmed: 34396637
Reg Anesth Pain Med. 2014 Sep-Oct;39(5):381-6
pubmed: 25025697
Mil Med. 2021 Jan 30;186(1-2):e98-e103
pubmed: 33038251
Br J Anaesth. 2013 Nov;111(5):711-20
pubmed: 23811426
J Cardiothorac Vasc Anesth. 2021 Nov;35(11):3294-3298
pubmed: 34140203
Reg Anesth Pain Med. 2016 Jan-Feb;41(1):43-9
pubmed: 26650430